Akt Family: Antibodies from Imgenex - Whois Article DirectoryArticle Directory Home Page


  Article AuthorsWelcome Guest   Article Category Map     RSS Feed Map   
    Whois Article Directory » Health » Cancer » Akt Family: Antibodies from Imgenex

Akt Family: Antibodies from ImgenexAkt Family: Antibodies from Imgenex

Article Author Info (Author: Stephen Jones | Article Views: 16 | Word Count: 329 | Published: Dec 30th 2007)

Get Akt Family: Antibodies from Imgenex HTML Code Get Html Code    Download - Akt Family: Antibodies from Imgenex - PDF  Download PDF    Print Akt Family: Antibodies from Imgenex Print View    Subscribe to this Author  Subscribe to this Author


Akt family of serine/threonine-directed kinases regulates a diverse array of biological processes, including cellular survival, proliferation, glucose homeostasis, and vascular tone and are important molecules in mammalian cellular signaling. The three widely expressed isoforms of PKB (PKB , PKBß and PKB ; also known as Akt1, Akt2 and Akt3, respectively) are each composed of an N-terminal PtdIns(3,4,5)P3- and PtdIns(3,4)P2-binding PH domain and a C-terminal kinase catalytic domain. Stimulation by numerous growth factors, cytokines, hormones and neurotransmitters can activate PKB/Akt in a phosphoinositide 3-kinase-dependent manner. Through receptor tyrosine kinases, these stimuli cause phosphoinositide 3-kinase activation, and generation of the membrane phospholipid PtdIns(3,4,5)P3. PtdIns(3,4,5)P3 then recruits PKB/Akt to the membrane, where it becomes phosphorylated (for PKB/Akt1) by upstream kinases, phosphoinositide-dependent kinase 1. Following the activation of PI 3-kinase, PKB isoforms are recruited from the cytosol to the plasma membrane through their interaction with PtdIns(3,4,5)P3 and/or PtdIns(3,4)P2 where they are thought to undergo a conformational change and become activated by phosphorylation of two residues. PKB can promote cell survival by inhibiting proteins that mediate apoptosis. Phosphorylation of BAD by PKB (and other AGC kinases) enables it to interact with 14-3-3 proteins, which prevents it from binding to Bcl-XL and thereby suppresses apoptosis. It directly phosphorylate and inhibit the caspase proteasesm, key executioners of apoptosis. PKBbeta, an essential gene for the maintenance of normal glucose homeostasis and is likely to represent a critical intermediate in the insulin signal transduction pathway. PKB activation might inhibit apoptosis by promoting the increased expression of survival molecules or the degradation of pro-apoptotic molecules. PKB also phosphorylates and activates endothelial nitric oxide synthase, thereby promoting angiogenesis (formation of new blood vessels). Inhibition of GSK3 following its phosphorylation by PKB has also been suggested to play a role in inhibiting apoptosis in neuronal cells. Thus it plays a key role in cancer progression by stimulating cell proliferation and inhibiting apoptosis, which suggests it, likely to be a hot drug target for the treatment of cancer, diabetes and stroke.


Bookmark




Akt Family: Antibodies from ImgenexAbout the Author

IMGENEX India Pvt Ltd. the only biotech company in Orissa and one of its kinds in Eastern India. IMGENEX India started in Oct as an outsourcing branch of IMGENEX Corporation, San Diego, USA. Find out more information about Akt Family.


Akt Family: Antibodies from Imgenex Source: http://WhoisArticleDirectory.com    Staff Article Edit Staff: Edit This Article


Read Other Related Articles


1: If Diagnosed with Mesothelioma Call a Doctor and Lawyer

2: Diagnosed with Mesothelioma? What this Means

3: Diagnosed with Mesothelioma? Call a Lawyer for Help

4: Can Eggplant Cure Skin Cancer?

5: Hot New Skin Cancer Breakthrough

6: Could Kennedy’s Tumor Have Been Caught 5 Years Ago?

7: Ovarian Cancer Prevention – 2008 Is Not Too Late

8: NF-kB Activation: Elucidating Upstream Events

9: Data Validation through Tissue Analysis

10: Are we "Livin" or just "Survivin"?



Rating: Not yet rated
Login to vote

Comments

No comments posted.

Add Your Comment


You do not have permission to comment. If you log in, you may be able to comment.

Join us Today - It's Free!